Showing results (1331-1340 of 1,459) with videos related to
Sort By:
Pageof 146
Leukemia|September 15, 2016
Maintenance therapy with decitabine in younger adults with acute myeloid leukemia in first remission: a phase 2 Cancer and Leukemia Group B Study (CALGB 10503)W Blum, B L Sanford, R Klisovic, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2005
Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B studyGuido Marcucci, Krzysztof Mrózek, Amy S Ruppert, et al.Blood Advances|October 17, 2017
A phase 2 study incorporating sorafenib into the chemotherapy for older adults with <i>FLT3</i>-mutated acute myeloid leukemia: CALGB 11001Geoffrey L Uy, Sumithra J Mandrekar, Kristina Laumann, et al.Plant Biotechnology Journal|August 1, 2012
Transposon tagging in diploid strawberryRichard E Veilleux, Kerri P Mills, Aaron J Baxter, et al.Leukemia|March 22, 2017
The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemiaA-K Eisfeld, K Mrózek, J Kohlschmidt, et al.The Journal of Clinical Endocrinology and Metabolism|February 12, 2005
Analysis of multiple data sets reveals no association between the insulin gene variable number tandem repeat element and polycystic ovary syndrome or related traitsBrenda L Powell, Lema Haddad, Amanda Bennett, et al.Cancer|January 3, 2014
Recombinant interleukin-2 in patients aged younger than 60 years with acute myeloid leukemia in first complete remission: results from Cancer and Leukemia Group B 19808Jonathan E Kolitz, Stephen L George, Don M Benson, et al.Leukemia|February 10, 2019
Complex karyotype in de novo acute myeloid leukemia: typical and atypical subtypes differ molecularly and clinicallyKrzysztof Mrózek, Ann-Kathrin Eisfeld, Jessica Kohlschmidt, et al.Science (New York, N.Y.)|February 26, 2016
Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusionThomas Delong, Timothy A Wiles, Rocky L Baker, et al.Molecular Oncology|October 27, 2020
SMARCA4 mutations in KRAS-mutant lung adenocarcinoma: a multi-cohort analysisLiang Liu, Tamjeed Ahmed, William J Petty, et al.Pageof 146